CLASS II Drug recall · Reported 5 Feb 2014 · FDA Enforcement Report

Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII recalled

Watson Laboratories is recalling Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, distributed nationwide in the US. The recall was initiated on 15 Jan 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 697316A, Expiry: Mar 2015.
Quantity recalled717 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1053-2014
FDA event ID
67348
Recalling firm
Watson Laboratories, Corona, CA
Classification
Class II
Status
Terminated
Recall initiated
15 Jan 2014
FDA classified
30 Jan 2014
Reported
5 Feb 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

15 Jan 2014Recall initiated by company
30 Jan 2014Classified by FDA+15 days
5 Feb 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Tablet/Capsule Specifications; Product contains broken tablets.

Product as listed by the FDA

Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by Watson Laboratories, Inc., Corona, CA 92880. Distributed by: Watson Pharma, Inc. NDC: 00591-0517-01.

Where it was distributed

Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI.

Nationwide ArizonaCaliforniaConnecticutFloridaNevadaOhioOklahomaPennsylvaniaSouth CarolinaWisconsin

Questions about this recall

Is Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg recalled?

Yes. Watson Laboratories recalled Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg on 15 Jan 2014. The recall is Class II and its status is Terminated. Recall number D-1053-2014.

Why was it recalled?

Failed Tablet/Capsule Specifications; Product contains broken tablets.

Which lots are affected?

Lot #: 697316A, Expiry: Mar 2015.

Where was it sold?

Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Watson Laboratories

All 22

Other Hydrocodone bitartrate and acetaminophen recalls

All 11